Dynamic nano-assemblies based on two-dimensional inorganic nanoparticles: Construction and preclinical demonstration

Adv Drug Deliv Rev. 2022 Jan:180:114031. doi: 10.1016/j.addr.2021.114031. Epub 2021 Nov 1.

Abstract

Dynamic drug delivery systems (DDSs) have the ability of transforming their morphology and functionality in response to the biological microenvironments at the disease site and/or external stimuli, show spatio-temporally controllable drug delivery, and enhance the treatment efficacy. Due to the large surface area and modification flexibility, two-dimensional (2D) inorganic nanomaterials are being increasingly exploited for developing intelligent DDSs for biomedical applications. In this review, we summarize the engineering methodologies used to construct transformable 2D DDSs, including changing compositions, creating defects, and surface dot-coating with polymers, biomolecules, or nanodots. Then we present and discuss dynamic inorganic 2D DDSs whose transformation is driven by the diseased characteristics, such as pH gradient, redox, hypoxia, and enzyme in the tumor microenvironment as well as the external stimuli including light, magnetism, and ultrasound. Finally, the limitations and challenges of current transformable inorganic DDSs for clinical translation and their in vivo safety assessment are discussed.

Keywords: Disassembly and reassembly; Dynamic drug delivery systems; Stimuli-driven theranostic; Surface functionalization; Transformable 2D inorganic nanomaterials; Tumor microenvironment.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Drug Delivery Systems*
  • Drug Evaluation, Preclinical
  • Humans
  • Inorganic Chemicals*
  • Molecular Structure
  • Nanostructures*

Substances

  • Inorganic Chemicals